IPSC
Price
$0.50
Change
+$0.02 (+4.17%)
Updated
Sep 5 closing price
Capitalization
43.6M
59 days until earnings call
ZURA
Price
$2.20
Change
+$0.13 (+6.28%)
Updated
Sep 5 closing price
Capitalization
143.04M
Interact to see
Advertisement

IPSC vs ZURA

Header iconIPSC vs ZURA Comparison
Open Charts IPSC vs ZURABanner chart's image
Century Therapeutics
Price$0.50
Change+$0.02 (+4.17%)
Volume$548.02K
Capitalization43.6M
Zura Bio
Price$2.20
Change+$0.13 (+6.28%)
Volume$368.72K
Capitalization143.04M
IPSC vs ZURA Comparison Chart in %
Loading...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPSC vs. ZURA commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPSC is a Hold and ZURA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (IPSC: $0.50 vs. ZURA: $2.20)
Brand notoriety: IPSC and ZURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPSC: 65% vs. ZURA: 59%
Market capitalization -- IPSC: $43.6M vs. ZURA: $143.04M
IPSC [@Biotechnology] is valued at $43.6M. ZURA’s [@Biotechnology] market capitalization is $143.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPSC’s FA Score shows that 0 FA rating(s) are green whileZURA’s FA Score has 0 green FA rating(s).

  • IPSC’s FA Score: 0 green, 5 red.
  • ZURA’s FA Score: 0 green, 5 red.
According to our system of comparison, ZURA is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPSC’s TA Score shows that 3 TA indicator(s) are bullish while ZURA’s TA Score has 4 bullish TA indicator(s).

  • IPSC’s TA Score: 3 bullish, 5 bearish.
  • ZURA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ZURA is a better buy in the short-term than IPSC.

Price Growth

IPSC (@Biotechnology) experienced а +2.64% price change this week, while ZURA (@Biotechnology) price change was +7.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.31%. For the same industry, the average monthly price growth was +11.21%, and the average quarterly price growth was +33.37%.

Reported Earning Dates

IPSC is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZURA($143M) has a higher market cap than IPSC($43.6M). ZURA YTD gains are higher at: -12.000 vs. IPSC (-50.030). IPSC has higher annual earnings (EBITDA): -6.16M vs. ZURA (-72.34M). IPSC (156M) and ZURA (154M) have equal amount of cash in the bank . IPSC has higher revenues than ZURA: IPSC (114M) vs ZURA (0).
IPSCZURAIPSC / ZURA
Capitalization43.6M143M30%
EBITDA-6.16M-72.34M9%
Gain YTD-50.030-12.000417%
P/E RatioN/A7.96-
Revenue114M0-
Total Cash156M154M101%
Total Debt51.5MN/A-
TECHNICAL ANALYSIS
Technical Analysis
IPSCZURA
RSI
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
48%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
60%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
56%
MACD
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
47%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
46%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 7 days ago
84%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
43%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
41%
View a ticker or compare two or three
Interact to see
Advertisement
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTTH0.05N/A
+8.81%
CTT Pharmaceutical Holdings, Inc.
NINOF11.400.40
+3.64%
Nikon Corp.
VWDRY6.560.19
+2.98%
Vestas Wind Systems A/S
ECRTF1.75N/A
N/A
Atex Resources Inc.
HLFN33.20N/A
N/A
Home Loan Financial Corp.

ZURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZURA has been loosely correlated with SYRE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ZURA jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZURA
1D Price
Change %
ZURA100%
+6.28%
SYRE - ZURA
44%
Loosely correlated
+0.06%
CGON - ZURA
43%
Loosely correlated
+6.88%
CCCC - ZURA
39%
Loosely correlated
+1.87%
LRMR - ZURA
39%
Loosely correlated
+1.81%
IPSC - ZURA
38%
Loosely correlated
+5.41%
More